Search

NIH Amends Clinical Trials Registration and Results Submission Rule

The National Institutes of Health (NIH) has issued a final rule making a technical amendment to its clinical trials registration and results submission regulation. This amendment updates the URL for accessing information on formatting and submission procedures from the old prsinfo.clinicaltrials.gov to the new clinicaltrials.gov website. The change is effective December 9, 2024.

NIH Delays Effective Date for Privacy Act Rule

The National Institutes of Health (NIH) has delayed the effective date of a final rule concerning a new Privacy Act system of records. The rule, originally set to take effect on February 18, 2025, is now delayed until March 21, 2025, in accordance with a presidential memorandum.

Uniformed Services University Board of Regents Meeting Notice

The Uniformed Services University of the Health Sciences (USUHS) has issued a notice for its Board of Regents quarterly meeting. The meeting will cover the approval of minutes, departmental reports, and degree conferrals, essential for maintaining accreditation and fulfilling the university's mission.

Proposed Rule to Remove Opioid Disorder Treatment Waiver Requirements

SAMHSA has issued a supplemental notice of proposed rulemaking to remove the waiver requirement for practitioners prescribing certain medications for opioid use disorder (OUD). This action follows amendments made by the Consolidated Appropriations Act, 2023, which eliminated the need for the waiver. Public comments are due by March 14, 2023.

SAMHSA Proposed Rule: Mandatory Drug Testing Guidelines Using Oral Fluid

The Substance Abuse and Mental Health Services Administration (SAMHSA) has issued a proposed rule to establish mandatory guidelines for drug testing using oral fluid. This proposal aims to provide a standardized framework for federal agencies and contractors conducting such testing.

Proposed Federal Workplace Drug Testing Guidelines

The Substance Abuse and Mental Health Services Administration (SAMHSA) has issued a proposed rule to update federal workplace drug testing guidelines. This consultation seeks public comment on the proposed changes to these guidelines.

Proposed Rule: Opioid Use Disorder Medication Regulations

The Department of Health and Human Services (HHS) has issued a Notice of Proposed Rulemaking to solicit public comment on proposed modifications to regulations concerning medications for opioid use disorder treatment. The comment period closes on February 14, 2023.

SAMHSA Seeks Public Comments on Maternal Mental Health

The Substance Abuse and Mental Health Services Administration (SAMHSA) is soliciting public comments on questions related to maternal mental health. This consultation aims to gather input for the Task Force on Maternal Mental Health.

HHS Opioid Use Disorder Medications Correction

The Department of Health and Human Services (HHS) is issuing a correcting amendment to the final rule on Medications for the Treatment of Opioid Use Disorder. This document corrects outdated references within the regulation, with an effective date of February 23, 2026.

HHS Proposes Rescinding LGBTQI+ Children Placement Rule

The Administration for Children and Families (ACF) proposes to remove a final rule concerning designated placement requirements for LGBTQI+ children in foster care. This action follows a court decision vacating the rule, which the court found exceeded HHS's statutory authority. The public comment period for this proposed rescission ends April 6, 2026.